Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*BioAv↝, *eff↓, *BioAv↝, *BioAv↝, *eff↑, *Half-Life∅, *eff↑, *eff↑, *Dose∅, *eff↑,
*BioAv↓, Half-Life∅, *BioAv↓, Dose∅, eff↑, CYP1A2↓, CYP2C9↓, CYP3A4↓,
*SREBF2↓, *HMGCR↓, *Dose∅, *BioAv?,
| - |
in-vitro, |
Nor, |
HDFa |
|
|
|
- |
in-vitro, |
PC, |
AsPC-1 |
|
|
|
- |
in-vitro, |
PC, |
MIA PaCa-2 |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
selectivity↑, selectivity↑, selectivity↓, ROS↑, eff↑, tumCV↓, MMP↓, Dose∅, eff↓, DNAdam↑, Apoptosis↑, TumAuto↑, Necroptosis↑, p‑P53↑, BIM↑, BAX↑, p‑PARP↑, Casp3↑, Casp8↑, Casp9↑, Cyt‑c↑, Bcl-2↓, AIF↑, p62↑, LC3B↑, MLKL↑, p‑MLKL↓, RIP3↑, p‑RIP3↑, TumCG↑, TumW↓,
*MAOA↓, *Dose∅, Dose?,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
PDKs↓, eff↑, ROS↑, PDK1↓, lactateProd↓, p‑PDH↑, Dose∅, OCR↑, DNA-PK↑, γH2AX↑, cl‑PARP↑, selectivity↑, *toxicity∅,
Dose∅, GSTs↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
AntiAg↝, Dose∅,
Dose∅, ROS⇅, Dose∅,
| - |
in-vitro, |
PC, |
PANC1 |
|
|
|
- |
in-vitro, |
Nor, |
H6c7 |
|
|
|
tumCV↓, ROS↑, eff↑, Dose∅, selectivity↑, MMP↓, mtDam↑, cl‑PARP↑, p‑ERK↓, p‑JNK↑, p‑p38↑, eff↓, ChemoSen↑,
*Dose∅, *AP-1↓, *MMP↑, *Casp3↓, *ROS↓,
Dose∅, Dose∅, eff↓, antiOx↑,
*DNAdam↑, *ROS↑, *Dose∅, *DNAdam∅,
| - |
in-vivo, |
Colon, |
NA |
|
|
|
- |
Human, |
Nor, |
NA |
|
|
|
TumCG↓, HDAC↓, *BioAv↑, Dose∅, Half-Life∅,
Dose∅, other↑,
Showing Research Papers: 1 to 16 of 16
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 16
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, GSTs↓, 1, ROS↑, 4, ROS⇅, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, MMP↓, 2, mtDam↑, 1, OCR↑, 1,
Core Metabolism/Glycolysis ⓘ
CYP3A4↓, 1, lactateProd↓, 1, p‑PDH↑, 1, PDK1↓, 2, PDKs↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, BIM↑, 1, Casp↑, 1, Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, Cyt‑c↑, 1, p‑JNK↑, 1, MLKL↑, 1, p‑MLKL↓, 1, Necroptosis↑, 1, p‑p38↑, 1,
Transcription & Epigenetics ⓘ
other↑, 1, tumCV↓, 2,
Autophagy & Lysosomes ⓘ
LC3B↑, 1, p62↑, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNA-PK↑, 1, DNAdam↑, 2, p‑P53↑, 1, p‑PARP↑, 1, cl‑PARP↑, 2, γH2AX↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑ERK↓, 1, HDAC↓, 1, mTOR⇅, 1, PTEN↑, 1, TumCG↓, 1, TumCG↑, 1,
Migration ⓘ
AntiAg↝, 1, RIP3↑, 1, p‑RIP3↑, 1, TSC1↑, 1, TumCP↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, CYP1A2↓, 1, CYP2C9↓, 1, Dose?, 1, Dose∅, 13, eff↓, 3, eff↑, 5, Half-Life∅, 2, selectivity↓, 1, selectivity↑, 5,
Clinical Biomarkers ⓘ
E6↓, 1, E7↓, 1,
Functional Outcomes ⓘ
TumW↓, 1,
Total Targets: 63
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1, ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 1,
Core Metabolism/Glycolysis ⓘ
SREBF2↓, 1,
Cell Death ⓘ
Casp3↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, DNAdam∅, 1,
Proliferation, Differentiation & Cell State ⓘ
HMGCR↓, 1,
Migration ⓘ
AP-1↓, 1,
Synaptic & Neurotransmission ⓘ
MAOA↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv?, 1, BioAv↓, 3, BioAv↑, 2, BioAv↝, 3, BioEnh↑, 1, Dose∅, 5, eff↓, 1, eff↑, 4, Half-Life∅, 2,
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 20
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1114 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page